TY - JOUR
T1 - Global, regional, and national sepsis incidence and mortality, 1990–2021
T2 - a systematic analysis
AU - GBD 2021 Global Sepsis Collaborators
AU - Gray, Authia P.
AU - Chung, Erin
AU - Hsu, Rebecca L.
AU - Araki, Daniel T.
AU - Gershberg Hayoon, Anna
AU - Davis Weaver, Nicole
AU - Swetschinski, Lucien R.
AU - Wool, Eve E.
AU - Han, Chieh
AU - Mestrovic, Tomislav
AU - Ikuta, Kevin S.
AU - Abbas, Nasir
AU - Abbasi, Madineh
AU - Abd ElHafeez, Samar
AU - Abdisa, Wakgari Mosisa
AU - Abdoun, Meriem
AU - Abdullahi, Auwal
AU - Abebe, Mesfin
AU - Abejew, Asrat Agalu
AU - Abie, Alemwork
AU - Abolhassani, Hassan
AU - Abukhadijah, Hana J.
AU - Achore, Meshack
AU - Adams, Lisa C.
AU - Adedokun, Kamoru Ademola
AU - Adesola, Ridwan Olamilekan
AU - Adiga, Usha
AU - Adnani, Qorinah Estiningtyas Sakilah
AU - Afolabi, Aanuoluwapo Adeyimika
AU - Agyemang-Duah, Williams
AU - Ahadi, Mahsa
AU - Ahmad, Aqeel
AU - Ahmed, Gasha Salih
AU - Ahmed, Haroon
AU - Ahmed, Meqdad Saleh
AU - Ahmed, Syed Anees
AU - Akter, Ema
AU - Alansari, Amani
AU - Albashtawy, Mohammed
AU - Aleidi, Shereen M.
AU - Alemnew, Fentahun
AU - Algammal, Abdelazeem M.
AU - Alhumaydhi, Fahad A.
AU - Ali, Mohammed Usman
AU - Ali, Rafat
AU - Ali, Syed Shujait
AU - Al-Iede, Montaha
AU - Al-Jabi, Samah W.
AU - Shahwan, Moyad Jamal
AU - Thangavelu, Lakshmi
N1 - Publisher Copyright:
© 2025 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0/
PY - 2025/12
Y1 - 2025/12
N2 - Background: The global burden of sepsis, a life-threatening dysregulated host response to infection leading to organ dysfunction, remains challenging to quantify. We aimed to comprehensively estimate the global, regional, and national burden of sepsis, including the impact of the COVID-19 pandemic and underlying causes of sepsis-related deaths with co-occurring infectious syndromes. Methods: We used multiple cause-of-death, hospital, minimally invasive tissue sampling, and linked death certificate and hospital record data representing 149 million deaths, covering 4290 location-years with mortality estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 to capture explicit and implicit sepsis cases and deaths. We estimated age-location-sex-specific fractions of sepsis-related deaths from 195 underlying causes of death and 22 infectious syndromes from 1990 to 2021 using binomial logistic regression models, and estimated sepsis-related deaths using GBD cause-specific mortality estimates. Using 250 million hospital admissions and 7·82 million deaths from hospital data, representing 1310 location-years, we modelled case fatality rates by use of binomial logistic regression, applied to sepsis death estimates to estimate sepsis incidence by age, location, and year. Findings: In 2021, we estimated 166 million (95% uncertainty interval 135–201) sepsis cases and 21·4 million (20·3–22·5) all-cause sepsis-related deaths globally, representing 31·5% of total global deaths. Sepsis-related deaths decreased between 1990 and 2019, followed by a surge in 2020 and 2021. As of 2021, individuals aged 15 years and older experienced increases across incidence (230%) and mortality (26·3%) since 1990. Those aged 70 years and older had the highest sepsis-related mortality in 2021 (9·28 million [8·74–9·86] deaths). Sepsis-related deaths from infectious underlying causes decreased from 11·8 million (11·1–12·5) in 1990 to 8·34 million (7·72–9·01) in 2019, then increased by 86·4% to 15·5 million (14·7–16·4) in 2021. Sepsis-related mortality due to non-infectious underlying causes of death increased from 4·69 million (4·35–5·05) in 1990 to 5·81 million (5·40–6·25) in 2021; the leading non-infectious underlying causes of death with sepsis were stroke, chronic obstructive pulmonary disease, and cirrhosis. In 2021, bloodstream infections inclusive of HIV and malaria (3·08 million [2·83–3·35]) and lower respiratory infections inclusive of COVID-19 (11·33 million [1·20–1·47]) were the most prominent infectious syndromes complicating sepsis-related deaths from non-infectious underlying causes, representing a consistent trend since 1990. Interpretation: The global burden of sepsis increased in 2020 and 2021, reversing progress from 1990. Sepsis incidence and mortality increased in people aged 15 years and older, especially those aged 70 years and older, and as a complication of non-infectious underlying causes of death such as stroke, primarily through bloodstream infections and lower respiratory infections. The global burden of sepsis is substantial, and sepsis is increasingly a complication of non-infectious causes of death. Funding: Gates Foundation, Wellcome Trust, and Department of Health and Social Care using UK aid funding managed by the Fleming Fund.
AB - Background: The global burden of sepsis, a life-threatening dysregulated host response to infection leading to organ dysfunction, remains challenging to quantify. We aimed to comprehensively estimate the global, regional, and national burden of sepsis, including the impact of the COVID-19 pandemic and underlying causes of sepsis-related deaths with co-occurring infectious syndromes. Methods: We used multiple cause-of-death, hospital, minimally invasive tissue sampling, and linked death certificate and hospital record data representing 149 million deaths, covering 4290 location-years with mortality estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 to capture explicit and implicit sepsis cases and deaths. We estimated age-location-sex-specific fractions of sepsis-related deaths from 195 underlying causes of death and 22 infectious syndromes from 1990 to 2021 using binomial logistic regression models, and estimated sepsis-related deaths using GBD cause-specific mortality estimates. Using 250 million hospital admissions and 7·82 million deaths from hospital data, representing 1310 location-years, we modelled case fatality rates by use of binomial logistic regression, applied to sepsis death estimates to estimate sepsis incidence by age, location, and year. Findings: In 2021, we estimated 166 million (95% uncertainty interval 135–201) sepsis cases and 21·4 million (20·3–22·5) all-cause sepsis-related deaths globally, representing 31·5% of total global deaths. Sepsis-related deaths decreased between 1990 and 2019, followed by a surge in 2020 and 2021. As of 2021, individuals aged 15 years and older experienced increases across incidence (230%) and mortality (26·3%) since 1990. Those aged 70 years and older had the highest sepsis-related mortality in 2021 (9·28 million [8·74–9·86] deaths). Sepsis-related deaths from infectious underlying causes decreased from 11·8 million (11·1–12·5) in 1990 to 8·34 million (7·72–9·01) in 2019, then increased by 86·4% to 15·5 million (14·7–16·4) in 2021. Sepsis-related mortality due to non-infectious underlying causes of death increased from 4·69 million (4·35–5·05) in 1990 to 5·81 million (5·40–6·25) in 2021; the leading non-infectious underlying causes of death with sepsis were stroke, chronic obstructive pulmonary disease, and cirrhosis. In 2021, bloodstream infections inclusive of HIV and malaria (3·08 million [2·83–3·35]) and lower respiratory infections inclusive of COVID-19 (11·33 million [1·20–1·47]) were the most prominent infectious syndromes complicating sepsis-related deaths from non-infectious underlying causes, representing a consistent trend since 1990. Interpretation: The global burden of sepsis increased in 2020 and 2021, reversing progress from 1990. Sepsis incidence and mortality increased in people aged 15 years and older, especially those aged 70 years and older, and as a complication of non-infectious underlying causes of death such as stroke, primarily through bloodstream infections and lower respiratory infections. The global burden of sepsis is substantial, and sepsis is increasingly a complication of non-infectious causes of death. Funding: Gates Foundation, Wellcome Trust, and Department of Health and Social Care using UK aid funding managed by the Fleming Fund.
UR - https://www.scopus.com/pages/publications/105021942517
U2 - 10.1016/S2214-109X(25)00356-0
DO - 10.1016/S2214-109X(25)00356-0
M3 - Article
C2 - 41135560
AN - SCOPUS:105021942517
SN - 2572-116X
VL - 13
SP - e2013-e2026
JO - The Lancet Global Health
JF - The Lancet Global Health
IS - 12
ER -